Herein, we found that BGB-3111 strongly inhibited cell proliferation, induced cell cycle arrest in the G1/G0-phase, and promoted cell apoptosis in the MCL cells expressing BTK, and showed a restricted off-target activity on ITK protein compared to ibrutinib. This evidence concerns the gene BTK and mantle cell lymphoma.